Delivery Order SPE2DB20D3101-SPE2DB23FRCH5
Award Date 2/9/23
Potential Completion Date 2/10/23
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,972.98 firm fixed-price delivery order is for the supply of insulin aspart 100 unit/mL vials, with a period of performance through January 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $8,765.68, was granted to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $3,013.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/mL medication, a critical pharmaceutical product used in the treatment of diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,681.56 Firm Fixed Price delivery order is for the provision of Insulin Aspart 100 Unit/mL vials. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as the...
- This federal contract award, valued at $3,764.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL pens. The contract is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of insulin aspart 100 unit/mL vials, a critical pharmaceutical product for the management of diabetes. The contract, valued at $5,391.27, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/ML VL 10ML. The contract has a firm fixed price of $4,746.50 and a completion date of January 19, 2024. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical division. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,610.83 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML medical products. The contract has an ultimate completion date of December 26, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,822.60, is for the delivery of Insulin Aspart 100 Unit/ML Vials 10ML to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $12,827.15 firm fixed-price delivery order contract for 4,564,313,868 units of insulin aspart 100 unit/mL pen, 3mL. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...